Home LiteratureArticle Details
PMID: 10737771 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.

Lu J, McKinsey TA, Nicol RL, Olson EN

Abstract

Myocyte enhancer factor-2 (MEF2) transcription factors control muscle-specific and growth factor-inducible genes. We show that hypertrophic growth of cardiomyocytes in response to phenylephrine and serum is accompanied by activation of MEF2 through a posttranslational mechanism mediated by calcium, calmodulin-dependent protein kinase (CaMK), and mitogen-activated protein kinase (MAPK) signaling. CaMK stimulates MEF2 activity by dissociating class II histone deacetylases (HDACs) from the DNA-binding domain. MAPKs, which activate MEF2 by phosphorylation of the transcription activation domain, maximally stimulate MEF2 activity only when repression by HDACs is relieved by CaMK signaling to the DNA-binding domain. These findings identify MEF2 as an endpoint for hypertrophic stimuli in cardiomyocytes and demonstrate that MEF2 mediates synergistic transcriptional responses to the CaMK and MAPK signaling pathways by signal-dependent dissociation from HDACs.

MeSH Terms
Animals Calcium-Calmodulin-Dependent Protein Kinases/metabolism Cells, Cultured DNA-Binding Proteins/metabolism Histone Deacetylases/metabolism MEF2 Transcription Factors Mice Myogenic Regulatory Factors Rats Signal Transduction Transcription Factors/metabolism Transcription, Genetic
Chemicals
DNA-Binding Proteins MEF2 Transcription Factors Myogenic Regulatory Factors Transcription Factors Calcium-Calmodulin-Dependent Protein Kinases Histone Deacetylases
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lu J
Department of Molecular Biology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75235-9148, USA.
McKinsey T A
Nicol R L
Olson E N
References (40)
40 references, click to expand
  1. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.
    Curr Biol. 1999 Oct 21;9(20):1203-6 PMID: 10531040
  2. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?
    J Cell Biol. 1998 Jul 27;142(2):523-35 PMID: 9679149
  3. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes.
    Mol Cell Biol. 1989 Nov;9(11):5022-33 PMID: 2601707
  4. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.
    Genes Dev. 1992 Sep;6(9):1783-98 PMID: 1516833
  5. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors.
    Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5282-6 PMID: 8506376
  6. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.
    Mol Cell Biol. 1994 Mar;14(3):1647-56 PMID: 8114702
  7. Involvement of cytoplasmic calcium and protein kinases in the regulation of atrial natriuretic factor secretion by contraction rate and endothelin.
    J Biol Chem. 1994 Apr 1;269(13):9466-72 PMID: 7511588
  8. Characterization of Ca2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation.
    J Biol Chem. 1994 Jun 3;269(22):15520-7 PMID: 8195196
  9. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.
    Development. 1994 May;120(5):1251-63 PMID: 8026334
  10. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila.
    Science. 1995 Feb 3;267(5198):688-93 PMID: 7839146
  11. Regulatory role of MEF2D in serum induction of the c-jun promoter.
    Mol Cell Biol. 1995 Jun;15(6):2907-15 PMID: 7760790
  12. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis.
    Mol Cell Biol. 1995 Nov;15(11):6364-76 PMID: 7565789
  13. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta).
    J Biol Chem. 1996 Jul 26;271(30):17920-6 PMID: 8663524
  14. CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV.
    Science. 1998 Sep 4;281(5382):1505-9 PMID: 9727976
  15. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.
    Nucleic Acids Res. 1998 Oct 15;26(20):4771-7 PMID: 9753748
  16. Regulation of the MEF2 family of transcription factors by p38.
    Mol Cell Biol. 1999 Jan;19(1):21-30 PMID: 9858528
  17. Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers.
    J Biol Chem. 1999 Jan 22;274(4):2440-5 PMID: 9891014
  18. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins.
    Annu Rev Cell Dev Biol. 1998;14:167-96 PMID: 9891782
  19. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor.
    J Biol Chem. 1999 Feb 19;274(8):5193-200 PMID: 9988769
  20. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p.
    J Biol Chem. 1999 Apr 23;274(17):11713-20 PMID: 10206986
  21. Three proteins define a class of human histone deacetylases related to yeast Hda1p.
    Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4868-73 PMID: 10220385
  22. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.
    Mol Cell Biol. 1999 Jun;19(6):4028-38 PMID: 10330143
  23. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5.
    Mol Cell Biol. 1999 Jun;19(6):4289-301 PMID: 10330170
  24. Post-translational control of the MEF2A transcriptional regulatory protein.
    Nucleic Acids Res. 1999 Jul 1;27(13):2646-54 PMID: 10373581
  25. Cardiac hypertrophy: sorting out the circuitry.
    Curr Opin Genet Dev. 1999 Jun;9(3):267-74 PMID: 10377279
  26. MEF-2 function is modified by a novel co-repressor, MITR.
    EMBO J. 1999 Sep 15;18(18):5085-98 PMID: 10487760
  27. HDAC4 deacetylase associates with and represses the MEF2 transcription factor.
    EMBO J. 1999 Sep 15;18(18):5099-107 PMID: 10487761
  28. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.
    Mol Cell Biol. 1999 Nov;19(11):7816-27 PMID: 10523670
  29. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation.
    Genes Dev. 1996 Oct 1;10(19):2478-90 PMID: 8843199
  30. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C.
    Mol Cell Biol. 1997 Feb;17(2):1010-26 PMID: 9001254
  31. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member.
    EMBO J. 1997 Jan 2;16(1):143-53 PMID: 9009275
  32. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation.
    Nature. 1997 Mar 20;386(6622):296-9 PMID: 9069290
  33. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
    Cell. 1997 Aug 22;90(4):595-606 PMID: 9288740
  34. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.
    EMBO J. 1997 Dec 1;16(23):7054-66 PMID: 9384584
  35. The nuclear deltaB isoform of Ca2+/calmodulin-dependent protein kinase II regulates atrial natriuretic factor gene expression in ventricular myocytes.
    J Biol Chem. 1997 Dec 5;272(49):31203-8 PMID: 9388275
  36. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.
    J Biol Chem. 1998 Jan 16;273(3):1741-8 PMID: 9430721
  37. Epidermal growth factor induction of the c-jun promoter by a Rac pathway.
    Mol Cell Biol. 1998 Feb;18(2):1065-73 PMID: 9448004
  38. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
    Cell. 1998 Apr 17;93(2):215-28 PMID: 9568714
  39. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs).
    FEBS Lett. 1998 Apr 10;426(1):93-6 PMID: 9598985
  40. The language of covalent histone modifications.
    Nature. 2000 Jan 6;403(6765):41-5 PMID: 10638745
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2000-04-11
Pages
4070-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC18151
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com